"Piloting FDA SHIELD's LOINC to In Vitro Diagnostic (LIVD) Specification in ..."

Greg Rehwoldt et al. (2021)

> Home

Details and statistics

DOI: —

access: closed

type: Conference or Workshop Paper

metadata version: 2024-04-17

- view
  - electronic edition @ amia.org (archived)
  - lookup Internet Archive Scholar
- export record
  dblp key:
  - conf/amia/RehwoldtCSAWSP21
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/conf/amia/RehwoldtCSAWSP21
Greg Rehwoldt, Raja Arul Cholan, Andrew K. Sills, I Khalil Appleton, Timothy Williams, Natalie M. Scott, Gregory Pappas:
Piloting FDA SHIELD's LOINC to In Vitro Diagnostic (LIVD) Specification in Five Medical Centers: Implications for Interoperability. AMIA 2021

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.